Shares of Precipio, Inc. (NASDAQ:PRPO – Get Free Report) crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $6.09 and traded as high as $7.00. Precipio shares last traded at $6.61, with a volume of 4,876 shares.
Precipio Stock Performance
The company has a debt-to-equity ratio of 0.02, a current ratio of 0.73 and a quick ratio of 0.60. The company has a 50 day simple moving average of $5.99 and a 200-day simple moving average of $6.09. The stock has a market cap of $9.79 million, a P/E ratio of -3.61 and a beta of 1.42.
Precipio (NASDAQ:PRPO – Get Free Report) last released its earnings results on Wednesday, November 6th. The biotechnology company reported ($0.42) earnings per share for the quarter. Precipio had a negative net margin of 17.23% and a negative return on equity of 34.01%. The company had revenue of $5.21 million during the quarter.
Precipio Company Profile
Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.
See Also
- Five stocks we like better than Precipio
- What is the Australian Securities Exchange (ASX)
- 3 Must-Have ETFs Set to Dominate This Quarter
- Are Penny Stocks a Good Fit for Your Portfolio?
- Seeking Stability? These 3 Stocks Offer Strong Potential
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.